# National Cancer Institute (NCI)'s Biotech Investments: 34 Startups in Its Portfolio (2026) > The 34 Biotech startups National Cancer Institute (NCI) has backed, by stage: $361M raised between them. From the rounds we track; updated nightly. Source: https://millionrounds.com/portfolio-maps/national-cancer-institute-nci-biotech-portfolio (Millionrounds; every figure on the page links to its filing or article) ## Stage not reported 27 - [*I* Igenica](https://millionrounds.com/company/igenica) - [Tiga TX](https://millionrounds.com/company/tiga-tx) - [Linnaeus Therapeutics](https://millionrounds.com/company/linnaeus-therapeutics) - [Transcode Therapeutics](https://millionrounds.com/company/transcode-therapeutics) - [Microvascular Therapeutics](https://millionrounds.com/company/microvascular-therapeutics) - [Helocyte](https://millionrounds.com/company/helocyte) - [Resolute Science](https://millionrounds.com/company/resolute-science) - [Lamassu Pharma](https://millionrounds.com/company/lamassu-pharma) - [Trethera](https://millionrounds.com/company/trethera) - [Intus Bio](https://millionrounds.com/company/intus-bio) - [Xylyx Bio](https://millionrounds.com/company/xylyx-bio) - [KinaRx](https://millionrounds.com/company/kinarx) - [Voximetry](https://millionrounds.com/company/voximetry) - [Saros Therapeutics](https://millionrounds.com/company/saros-therapeutics) - [Flexomics](https://millionrounds.com/company/flexomics) - [Isabl Inc.](https://millionrounds.com/company/isabl-inc) - [Shasqi](https://millionrounds.com/company/shasqi) - [Reveal Pharmaceuticals](https://millionrounds.com/company/reveal-pharmaceuticals) - [AUM LifeTech](https://millionrounds.com/company/aum-lifetech) - [Oleolive](https://millionrounds.com/company/oleolive) - [Monon Bioventures](https://millionrounds.com/company/monon-bioventures) - [TumorGen](https://millionrounds.com/company/tumorgen) - [Paramita Therapeutics](https://millionrounds.com/company/paramita-therapeutics) - [Kovina Therapeutics](https://millionrounds.com/company/kovina-therapeutics) +3 more ## Series B 3 - [*CT* Chrono Therapeutics](https://millionrounds.com/company/chrono-therapeutics) - [Previse](https://millionrounds.com/company/previse) - [Immunicom](https://millionrounds.com/company/immunicom) ## Series A 2 - [AiM Medical Robotics](https://millionrounds.com/company/aim-medical-robotics) - [Agilvax](https://millionrounds.com/company/agilvax) ## Pre-seed and seed 2 - [Vivere Oncotherapies](https://millionrounds.com/company/vivere-oncotherapies) - [*MB* Modifi Bio](https://millionrounds.com/company/modifi-bio) ## Segment by segment ### Stage not reported 27 startups · $217M raised - [*I* **Igenica**](https://millionrounds.com/company/igenica) Igenica engages in discovery and development of antibody-based therapeutics for the treatment of cancer. United States $88M - [**Tiga TX**](https://millionrounds.com/company/tiga-tx) Tiga TX develops an IgA therapeutic monoclonal antibody platform for the treatment of solid tumors. United States $36M - [**Linnaeus Therapeutics**](https://millionrounds.com/company/linnaeus-therapeutics) Linnaeus Therapeutics is a development stage biotech company that develops and commercializes drugs for cancer. United States $32M - [**Transcode Therapeutics**](https://millionrounds.com/company/transcode-therapeutics) TransCode Therapeutics is an RNA oncology company that develops and commercializes drugs for the treatment of metastatic cancer. United States $26M - [**Microvascular Therapeutics**](https://millionrounds.com/company/microvascular-therapeutics) Microvascular Therapeutics is a biotechnology company specializing in ultrasound contrast and theranostics for diagnosis. United States $4.0M - [**Helocyte**](https://millionrounds.com/company/helocyte) Helocyte is a clinical-stage biopharmaceutical company developing novel immunotherapies for the prevention and treatment of cancer. United States $3.2M - [**Resolute Science**](https://millionrounds.com/company/resolute-science) Resolute is creating a new class of medicines for aggressive solid tumors that are uncommon and challenging to treat. United States $2.9M - [**Lamassu Pharma**](https://millionrounds.com/company/lamassu-pharma) Lamassu Pharma is a biotech startup that solves the critical unmet medical need for severe acute pancreatitis. United States $2.7M ### Series B 3 startups · $109M raised - [*CT* **Chrono Therapeutics**](https://millionrounds.com/company/chrono-therapeutics) Chrono Therapeutics was founded by Guy DiPierro to cause a paradigm shift in the way addictions and diseases are treated. United States $83M - [**Previse**](https://millionrounds.com/company/previse) Previse is a London-based financial services and technology company that focuses on improving payment processes for businesses. United Kingdom $23M - [**Immunicom**](https://millionrounds.com/company/immunicom) Immunicom is a biotechnology company. United States $3.9M ### Series A 2 startups · $21M raised - [**AiM Medical Robotics**](https://millionrounds.com/company/aim-medical-robotics) AiM Medical Robotics is a privately held company based in Worcester, Massachusetts, focused on developing a portable, MRI-compatib United States $16M - [**Agilvax**](https://millionrounds.com/company/agilvax) Agilvax is a biotechnological company that focuses on the discovery and development of immunotherapies and targeted vaccines. United States $4.7M ### Pre-seed and seed 2 startups · $14M raised - [**Vivere Oncotherapies**](https://millionrounds.com/company/vivere-oncotherapies) Vivere Oncotherapies is a biotechnology company based in Berkeley, California, founded in 2022. United States $10M - [*MB* **Modifi Bio**](https://millionrounds.com/company/modifi-bio) Modifi Biosciences is a leader in direct DNA modification and the development of novel cancer therapeutics. United States $4.3M **How this map is made.** Every startup here works in Biotech and has raised money in a round we track that names National Cancer Institute (NCI) as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026. ## More portfolio maps [All portfolios](https://millionrounds.com/portfolio-maps) [Portfolio map **National Cancer Institute (NCI) portfolio map** 47 startups · $494M](https://millionrounds.com/portfolio-maps/national-cancer-institute-nci-portfolio-map)[Sector portfolio **National Institute of Allergy and Infectious Diseases' Biotech portfolio** 28 startups · $407M](https://millionrounds.com/portfolio-maps/national-institute-of-allergy-and-infectious-diseases-biotech-portfolio)[Sector portfolio **Mayo Clinic's Healthtech portfolio** 22 startups · $2.1B](https://millionrounds.com/portfolio-maps/mayo-clinic-healthtech-portfolio)[Sector portfolio **Mayo Clinic's Biotech portfolio** 19 startups · $479M](https://millionrounds.com/portfolio-maps/mayo-clinic-biotech-portfolio)[Sector portfolio **AVP's AI portfolio** 17 startups · $1.1B](https://millionrounds.com/portfolio-maps/avp-2-ai-portfolio)[Sector portfolio **Square 1 Bank's Biotech portfolio** 14 startups · $1.6B](https://millionrounds.com/portfolio-maps/square-1-bank-biotech-portfolio) ## Raising from investors like National Cancer Institute (NCI)? Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports. [Find investors](https://millionrounds.com/login?join=1&next=/app/investors)[Market maps](https://millionrounds.com/market-maps)